Published in Proteomics Weekly, October 4th, 2004
"The pathogenesis of inflammatory diseases is determined by a malfunction of the immune system. Up to now therapies have not been able to cure but to interfere in a more or less specific way with the immune function. The great increase of knowledge in immunology made it possible to develop new medications, which alter the immune system in a specific way," scientists from Germany reported.
"The advantage is the relative simple way of developing new medications by using monoclonal antibodies against specific antigens and testing the hypothesis in animal model and in small...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Proteomics Weekly
Source: Proteomics Weekly (2004-10-04)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.